Rittmeyer, Achim
Barlesi, Fabrice
Waterkamp, Daniel
Park, Keunchil
Ciardiello, Fortunato
von Pawel, Joachim
Gadgeel, Shirish M
Hida, Toyoaki
Kowalski, Dariusz M
Dols, Manuel Cobo
Cortinovis, Diego L
Leach, Joseph
Polikoff, Jonathan
Barrios, Carlos
Kabbinavar, Fairooz
Frontera, Osvaldo Arén
De Marinis, Filippo
Turna, Hande
Lee, Jong-Seok
Ballinger, Marcus
Kowanetz, Marcin
He, Pei
Chen, Daniel S
Sandler, Alan
Gandara, David R
This article is maintained by: Elsevier
Article Title: Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Journal Title: The Lancet
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S0140-6736(16)32517-X
CrossRef DOI link to the associated document: https://doi.org/10.1016/S0140-6736(16)32535-1
Content Type: article
Copyright: © 2016 Elsevier Ltd. All rights reserved.